Leerink Partnrs Upgrades CorMedix (NASDAQ:CRMD) to Strong-Buy
Leerink Partnrs upgraded shares of CorMedix (NASDAQ:CRMD – Free Report) to a strong-buy rating in a research note issued to investors on Friday morning,Zacks.com reports. Several other research firms have also issued reports on CRMD. Royal Bank of Canada lifted their price objective on shares of CorMedix from $11.00 to $12.00 and gave the company […]
Leerink Partnrs upgraded shares of CorMedix (NASDAQ:CRMD – Free Report) to a strong-buy rating in a research note issued to investors on Friday morning,Zacks.com reports. Several other research firms have also issued reports on CRMD. Royal Bank of Canada lifted their price objective on shares of CorMedix from $11.00 to $12.00 and gave the company […]
